11 Feb 2021
- Due to Hub: 11 February 2021
- External deadline: 25 February 2021
Asahi Kasei Pharma Open Innovation is an open innovation platform to recruit candidates for research collaborations related to drug discovery. The program aims to establish collaboration between Asahi Kasei and the applicant to collaborate to implement research. Asahei Kasei will work with the applicant to develop a joint research plan. Proposals are accepted under the following topics: Neurodegenerative disease, autoimmune diseases, critical care medicine, bone and/or cartilage, muscle-related disease.
For more information please see the funding body website. If you intend to submit an application to this scheme please contact your Research Hub before the date listed above: